PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.\', \'Division of Infectious Diseases and Tropical Medicine, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.\', \'Center for Virology, Medical University of Vienna, Vienna, Austria.\', \'Department of Neurology, Medical University of Vienna, Vienna, Austria.\', \'Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.\', \'Department of Pathology, Medical University of Vienna, Vienna, Austria.\', \'2nd Department of Medicine, Hietzing Hospital, Vienna, Austria.\', \'1st Medical Department, Hanusch Hospital, Vienna, Austria.\', \'School of Medicine, Sigmund Freud Private University Vienna, Vienna, Austria.\', \'Departement of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.\', \'Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria daniel.aletaha@meduniwien.ac.at.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1136/annrheumdis-2021-221558
?:doi
?:hasPublicationType
?:journal
  • Annals of the rheumatic diseases
is ?:pmid of
?:pmid
?:pmid
  • 35027397
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 7.699
?:rankingScore_hIndex
  • 198
is ?:relation_isRelatedTo_publication of
?:title
  • Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination: a randomised controlled trial.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all